News | Breast Imaging | July 12, 2022

The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. 

medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform

July 12, 2022 — The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. Recently, an SMGH team participated in its first breast-conserving surgical procedure using Molli. SMGH is the first hospital in the southwest Ontario region to use this technology. 

Molli Surgical’s Health Canada-approved and FDA-cleared Molli features the Molli Marker — the smallest localization marker on the market — and is designed to give a better patient experience over traditional wire localization. The Molli Wand detects the marker and visualizes its location on a tablet, helping surgeons locate lesions more efficiently with improved accuracy. Molli is also a great benefit for patients as it allows for more convenient scheduling of marker placement. 

“Molli is an innovative and revolutionary way of localizing breast masses that cannot be felt. It allows for a less painful and more effective way of finding the breast disease that needs to be removed, during surgery,” says Dr. Vipan Jain, MHA General Surgeon. “The marker can be inserted weeks before the surgical date, allowing for easier scheduling for patients and no loss of signal during surgery, making it a better option than the radioactive seed guide. Once placed, the chances of it moving and/or dislodging are virtually nonexistent, making it a better option than the conventional wire guide. We're seeing these benefits, and with the ease of use in the operating room, I believe Molli is a better option for patients.” 

“Congratulations to the team at SMGH and Molli Surgical for bringing this innovative, precision technology to our community — and for the difference it will make for Strathroy patients and for their families,” said Joanne Vanderheyden, Mayor of Strathroy-Caradoc

“We’re very pleased to do our part to help improve the patient experience with the use of Molli at Strathroy Middlesex General Hospital,” said Fazila Seker, President and CEO of Molli Surgical. “We believe that by improving the way we care for people who are experiencing breast surgery — together with creating more efficiency in radiology and surgery departments — creates a better overall experience for both physicians and their patients, and ultimately strengthens hospitals and the communities they serve.” 

For more information: http://mollisurgical.com/ 


Related Content

News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
News | Mammography

April 4, 2024 — Siemens Healthineers announces the Food and Drug Administration 510(k) clearance of the MAMMOMAT B ...

Time April 04, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a snapshot of the Top 10 most-read content from ITN's viewers during the month of March: 1. Philips Teams with ...

Time April 04, 2024
arrow
Subscribe Now